Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 54.00
Ask: 55.00
Change: -1.60 (-2.88%)
Spread: 1.00 (1.852%)
Open: 55.50
High: 56.00
Low: 54.00
Prev. Close: 55.60
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

17 Dec 2019 07:00

RNS Number : 0628X
SDI Group PLC
17 December 2019
 

 

 

 

 

 

 

SDI Group plc

 

("SDI", "SDI Group", "the Company", or "the Group")

 

Interim results for the six months ended 31 October 2019

 

The Board of Directors of SDI Group plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, is pleased to announce another strong set of results and solid operational progress for the six months to end October 2019.

 

 

Highlights

 

·; Revenue increased by 42% to £11.45m (2018: £8.05m)

·; Revenue growth both organic (6.4%) and from acquisitions (35.8%)

·; Adjusted Operating Profit* increased 41% to £2.10m (2018: £1.49m)

- Statutory operating profit increased 32% to £1.62m (2018: £1.23m)

·; Adjusted Profit Before Tax* increased 36% to £2.00m (2018: £1.46m)

- Profit before taxation increased 27% to £1.52m (2018: £1.20m)

·; Adjusted diluted EPS* increased 28% to 1.70p (2018: 1.33p)

- Statutory diluted EPS increased by 20% to 1.32p (2018: 1.10p)

·; Cash generated from operations increased 34% to £2.05m (2018: £1.53m)

·; Net debt** at 31 October 2019 was £0.57m (30 April 2019: net debt of £1.51m)

·; On 29 November 2019, after the end of the reporting period, SDI acquired Chell Instruments Limited for a consideration of £4.3m plus an additional cash payment for net assets at completion. 

 * before reorganisation costs, acquisition and fundraising costs, amortisation of acquired intangibles and share based payments

** bank finance less cash and cash equivalents

 

Ken Ford, Chairman of SDI, said:

 

"The Group has made a good start to the financial year. Despite the potential for economic variability, influenced by political conditions (including Brexit) and currency fluctuations, the Board is confident that our diversified portfolio of businesses is on course to deliver a full year financial performance in line with market expectations."

 

 

Enquiries

SDI Group plc 01223 320480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.scientificdigitalimaging.com

 

finnCap Ltd 020 7220 0500

Ed Frisby/Kate Washington - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

JW Communications 07818 430877

Julia Wilson - Investor & Public Relations

About SDI Group plc:

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries and Fistreem.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

The interim report can also be viewed on the Company's website: www.scientificdigitalimaging.com

 

Chairman's statement

 

For the six month period ended 31 October 2019, we are pleased to report that the SDI Group plc ("SDI") revenues, gross margin, adjusted profits and profit before taxation all show continuing solid progress. The Group, including the 2019 acquisitions of Thermal Exchange Limited, Graticules Optics Limited and MPB Industries Limited, is trading in line with expectations.

 

To reflect the changing nature of our company portfolio, which includes many businesses with technology unrelated to digital imaging, on 30 October 2019 we changed the Company name from Scientific Digital Imaging plc to SDI Group plc. No acquisitions were completed in the period as successful consolidation and integration of SDI's new and existing companies was the Group's immediate priority.

 

Now that these internal activities have been completed, the Board has again been actively seeking to acquire further companies to add to its portfolio.

 

Revenues

 

Group revenues increased by 42% to £11.45m (2018: £8.05m). Turnover from our five sensors and control companies grew by 58% to £5.80m (2018: £3.67m) with Sentek, Astles and Applied Thermal Control all showing double digit increases. The digital imaging segment grew by 29%, with Atik continuing to grow and Graticules Optics, one of our newly acquired businesses, both increasing sales over the same period last year and posting a significantly increased order book.

 

Sales of our largely niche technologies remain evenly divided across North America, the UK and rest of Europe and China, which is helping to offset some of the Brexit uncertainty around trading in Europe. The order book remains in line with expectations as many of our businesses continue to supply OEM products and components to fixed-term call-off contracts for major industrial and life science equipment providers.

 

Profits

 

Group profit before tax increased by 27% to £1.52m (2018: £1.20m). The increase in profitability was driven by organic revenue growth (6%) and by the contributions from businesses acquired in the preceding year.

 

We continue to provide shareholders with adjusted profit numbers to help them better understand underlying operating performance given variable acquisition-related costs and non-cash charges. The adjustments in this period totalled £481,000 before tax (2018: 265,000), and these include a £282,000 charge for amortisation of acquired intangible assets and £59,000 of reorganisation cost. Adjusted Profit Before Tax increased by 36%.

 

Basic earnings per share increased by 22% from 1.12p to 1.37p; fully diluted earnings per share also improved 20% to 1.32p (2018: 1.10p). Adjusted EPS increased by 28%.

 

Cash flow

 

Cash generated from operations increased by 34% to £2.05m (2018: £1.53m). Contributing to this was a reduction in average debtor days in both reporting segments. Capital expenditure, including leasehold improvements and for demo instruments increased to £226,000 from £69,000 in 2018. Net debt, bank finance less cash, reduced by £0.93m in the six month period.

 

Operations

 

Following on from investments at Sentek last year, SDI has been making further improvements to its production facilities in several locations:

- Fistreem is being relocated into the Synoptics site in Cambridge, UK, and its Loughborough site will be closed. Fistreem products are being assembled in Cambridge to better utilise manufacturing capacity; the facility is fully operational in December 2019.

- SDI signed a lease agreement on a new site in Leicestershire for co-locating Thermal Exchange and Applied Thermal Control to develop and manufacture their complementary chiller technologies. Both companies have relocated there in December 2019, enabling synergies in R&D and production expertise, as well as economies of scale in terms of overhead costs.

- The Atik Camera production site in Lisbon, Portugal has reached capacity. Therefore, from June 2019, SDI leased and is refurbishing a new site which will more than double manufacturing space, with the aim to relocate production there in January 2020.

The combined effect of these actions all in calendar 2019 is to reduce factory roof count by two units, while significantly increasing capacity, and improving the working environment for staff, efficiency and product quality, covering over 80% of our production output.

 

We have also made good progress in recruiting across the Group, filling key positions in sales, R&D, production and finance.

 

 

Acquisitions

 

After the period end, on 29 November 2019, SDI acquired Chell Instruments Limited ("Chell") for an initial consideration of £4.3m plus an additional cash payment for net assets at completion, still to be determined. Chell specialises in the design, manufacture and calibration of pressure, vacuum and gas flow measurement instruments for a variety of sectors including aerospace, vehicle aerodynamics, gas and steam turbine testing and power generation industries. For the year ended 31 December 2018, Chell achieved revenue of £4.7m, gross profit of £2.5m and profit before tax of £0.78m. The Board has identified areas within Chell that have the potential for growth using the strong management team the company has recruited over the years. The Acquisition is expected to be earnings enhancing in its first full year of ownership.

 

The acquisition was funded through an extension of our bank debt facility, which now consists of a £5.0m revolving facility (not fully drawn) and a £4.8m term loan, both expiring in April 2023.

 

Outlook

 

The Group has made a good start to the financial year. Despite the potential for economic variability, influenced by political conditions (including Brexit) and currency fluctuations, the Board is confident that our diversified portfolio of businesses is on course to deliver a full year financial performance in line with market expectations.

 

 

 

Ken Ford, Chairman

16 December 2019

 

 

 

 

 

 

 

Product Portfolio

 

Digital Imaging

 

The digital imaging segment consists of three divisions, Atik Cameras, Graticules Optics and Synoptics.

 

Atik Cameras

 

Atik Cameras offers three brands of camera:

(a) Atik - highly sensitive cameras for life science and industrial applications, as well as deep-sky astronomy;

(b) Quantum Scientific Imaging (QSI) - high performance cameras with applications in astronomy, life science and flat panel display inspection; and

(c) Opus Instruments - infrared reflectography cameras for art conservation and restoration.

 

Graticules Optics

 

Designs and manufactures precision micro pattern products on glass, film and metal foil.

Synoptics

 

Offers a range of instruments under four brands:

(a) Syngene - advanced systems for documentation and analysis of gels for molecular biologists. This brand utilises some of the range from Atik Cameras;

(b) Synbiosis - equipment for microbiologists to automate colony counting and zone measurement;

(c) Synoptics Health - ProReveal, to detect residual proteins on surgical instruments; and

(d) Fistreem - water purification products and vacuum ovens.

 

Sensors and Control

 

The sensors and control segment of SDI currently encompasses five divisions; Applied Thermal Control, Thermal Exchange, Astles Control Systems (Astles), MPB Industries and Sentek.

 

Applied Thermal Control and Thermal Exchange

 

Applied Thermal Control and Thermal Exchange manufacture and supply chillers, coolers and heat exchangers used within industrial, medical and scientific markets.

Astles Control Systems

 

Astles is a supplier of chemical dosing and control systems to manufacturing customers worldwide.

MPB Industries

 

Designs and manufactures flowmeters and other equipment for measuring liquids and gases for industrial and scientific applications.

 

Sentek

 

Sentek manufactures and markets off-the-shelf and custom-made, reusable and single-use electrochemical sensors for use in laboratory analysis, food, beverage, pharmaceutical and personal care manufacturing, as well as the leisure industry.

 

 

Consolidated income statement

Unaudited for the six months ended 31 October 2019

 

 

 

 

 

 

 

Note

 

6 months to

31 October

2019

Unaudited

£'000

 

6 months to

31 October

2018

Unaudited

£'000

 

12 months to

30 April

2019

Audited

£'000

Revenue

 

 

11,445

 

8,047

 

17,427

Costs of sales

 

 

(3,680)

 

(2,736)

 

(5,902)

Gross Profit

 

 

7,765

 

5,311

 

11,525

 

 

 

 

 

 

 

 

Operating expenses

 

 

(6,144)

 

(4,082)

 

(9,327)

 

 

 

 

 

 

 

 

Analysed as:

 

 

 

 

 

 

 

Reorganisation costs

 

(59)

 

(4)

 

(124)

 

Share based payments

 

(140)

 

(48)

 

(136)

 

Acquisition and fundraising costs

 

-

 

(60)

 

(288)

 

Amortisation of acquired intangible assets

 

 

(282)

 

 

(153)

 

 

(356)

 

Other operating costs

 

(5,663)

 

(3,817)

 

(8,423)

 

Operating expenses

 

(6,144)

 

(4,082)

 

(9,327)

 

 

 

 

 

 

 

 

 

Operating profit

 

 

1,621

 

1,229

 

2,198

Net financing expense

 

 

(104)

 

(30)

 

(77)

Profit before taxation

 

 

1,517

 

1,199

 

2,121

Income tax charge

 

 

(189)

 

(203)

 

(209)

Profit for the period

 

 

1,328

 

996

 

1,912

Earnings per share

5

 

 

 

 

 

 

Basic earnings per share

 

 

1.37p

 

1.12p

 

2.10p

Diluted earnings per share

 

 

1.32p

 

1.10p

 

2.05p

 

 

 

 

Consolidated statement of comprehensive income

Unaudited for the six months ended 31 October 2019

 

 

 

6 months to

31 October

2019

Unaudited

£'000

6 months to

31 October

2018

Unaudited

£'000

12 months to

30 April

2019

Audited

£'000

Profit for the period

 

1,328

996

1,912

Other comprehensive income

 

 

 

 

Exchange differences on translating foreign operations

 

 

26

 

50

 

31

Total comprehensive profit for the period

 

 

1,354

 

1,046

 

1,943

 

 

Consolidated balance sheet

Unaudited at 31 October 2019

 

 

Note

31 October

2019

Unaudited

£'000

31 October

2018

Unaudited

£'000

30 April

2019

Audited

£'000

Assets

 

 

 

 

Non-current assets

 

 

 

 

Intangible assets

 

16,900

11,299

17,194

Property, plant and equipment

 

3,281

370

767

Deferred tax asset

 

182

27

180

 

 

20,363

11,696

18,141

Current assets

 

 

 

 

Inventories

 

2,785

2,200

2,576

Trade and other receivables

 

3,425

2,858

3,340

Cash and cash equivalents

 

2,727

2,307

2,494

 

 

8,937

7,365

8,410

Total assets

 

29,300

19,061

26,551

Liabilities

 

 

 

 

Non-current liabilities

 

 

 

 

Borrowings

6

5,358

1,378

4,016

Deferred tax liability

 

1,356

1,033

1,448

 

 

6,714

2,411

5,464

Current liabilities

 

 

 

 

Trade and other payables

 

2,927

2,392

3,280

Provisions for warranty

 

16

11

11

Borrowings

6

449

34

84

Current tax payable

 

597

494

626

 

 

3,989

2,931

4,001

Total liabilities

 

10,703

5,342

9,465

Net assets

 

18,597

13,719

17,086

Equity

 

 

 

 

Share capital

 

972

896

972

Merger reserve

 

3,030

3,030

3,030

Share premium account

 

8,696

6,390

8,696

Own shares held by Employee Benefit Trust

 

-

(17)

(17)

Other reserves

 

424

196

284

Foreign exchange reserve

 

166

159

140

Retained earnings

 

5,309

3,065

3,981

Total equity

 

18,597

13,719

17,086

 

 

 

Consolidated statement of cash flows

Unaudited for the six months ended 31 October 2019

 

 

6 months to

31 October

2019

Unaudited

£'000

6 months to

31 October

2018

Unaudited

£'000

12 months to

30 April

2019

Audited

£'000

Operating activities

 

 

 

Profit for the period

1,328

996

1,912

Depreciation, amortisation and impairment

919

629

1,202

Finance costs and income

104

30

77

(Decrease) / increase in provisions

5

-

(12)

Taxation expense in the income statement

189

203

209

Employee share based payments

140

47

136

Operating cash flow before movement in working capital

2,685

1,905

3,524

 

 

 

 

Changes in inventories

(201)

(34)

65

Changes in trade and other receivables

(94)

(529)

(415)

Changes in trade and other payables

(339)

189

446

Cash generated from operations

2,051

1,531

3,620

 

 

 

 

Interest paid

(104)

(30)

(77)

Income taxes paid

(312)

(8)

(319)

Cash generated from operating activities

1,635

1,493

3,224

 

 

 

 

Cash flows from investing activities

 

 

 

Capital expenditure on fixed assets

(226)

(54)

(413)

Sale of property plant and equipment

3

35

45

Expenditure on development and other intangibles

(257)

(273)

(591)

Acquisition of subsidiaries, net of cash

-

(744)

(6,668)

Deferred consideration paid

-

(152)

(152)

Net cash used in investing activities

(480)

(1,188)

(7,779)

 

 

 

 

Cash flows from financing activities

 

 

 

Payments of lease liabilities

(225)

(23)

(36)

Proceeds from bank borrowings

-

-

3,600

Repayment of borrowings

(700)

-

(970)

Issues of shares

-

-

2,449

Net cash from/(used in) financing activities

(925)

(23)

5,043

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

230

 

282

488

 

 

 

 

Cash and cash equivalents, beginning of period

2,494

2,007

2,007

Foreign currency movements on cash balances

3

18

(1)

Cash and cash equivalents, end of period

2,727

2,307

2,494

 

Consolidated statement of changes in equity

Unaudited for the six months ended 31 October 2019

 

6 months to 31 October 2019 - unaudited

Share

capital

£'000

Merger

reserve

£'000

Foreign

exchange

£'000

Share

premium

£'000

Own shares

held by EBT

£'000

Other

reserves

£'000

Retained

earnings

£'000

Total

£'000

Balance at 1 May 2019

972

3,030

140

8,696

(17)

284

3,981

17,086

Share based payments

-

-

-

-

-

140

-

140

Release of shares on option exercise

-

-

-

-

17

-

-

17

Transactions with owners

-

-

-

-

17

140

-

157

Profit for the period

-

-

-

-

-

-

1,328

1,328

Foreign exchange on consolidation of subsidiaries

 

-

 

-

 

26

 

-

 

-

 

-

 

-

 

26

Total comprehensive income for the period

 

-

 

-

 

26

 

-

 

-

 

-

 

1,328

 

1,354

Balance at 31 October 2019

972

3,030

166

8,696

-

424

5,309

18,597

 

 

6 months to 31 October 2018 - unaudited

Share

capital

£'000

Merger

reserve

£'000

Foreign

exchange

£'000

Share

premium

£'000

Own shares

held by EBT

£'000

Other

reserves

£'000

Retained

earnings

£'000

Total

£'000

Balance at 1 May 2017

896

3,030

109

6,390

(82)

148

2,069

12,560

Share based payments

-

-

-

-

-

48

-

48

Release of shares on option exercise

-

-

-

-

65

-

-

65

Transactions with owners

-

-

-

-

65

48

-

113

Profit for the period

-

-

-

-

-

-

996

996

Foreign exchange on consolidation of subsidiaries

 

-

 

-

 

50

 

-

 

-

 

-

 

-

 

50

Total comprehensive income for the period

 

-

 

-

 

50

 

-

 

-

 

-

 

996

 

1,046

Balance at 31 October 2017

896

3,030

159

6,390

(17)

196

3,065

13,719

 

 

12 months to 30 April 2019 - audited

Share

capital

£'000

Merger

reserve

£'000

Foreign

exchange

£'000

Share

premium

£'000

Own shares

held by EBT

£'000

Other

reserves

£'000

Retained

earnings

£'000

Total

£'000

Balance at 1 May 2018

896

3,030

109

6,390

(82)

148

2,069

12,560

Shares issued

76

-

-

2,306

65

-

-

2,447

Share based payments

-

-

-

-

-

136

-

136

Transactions with owners

76

-

-

2,306

65

136

-

2,583

Profit for the year

-

-

-

-

-

-

1,912

1,912

Foreign exchange on consolidation of subsidiaries

 

-

 

-

 

31

 

-

 

-

 

-

 

-

 

31

Total comprehensive income

-

-

31

-

-

-

1,912

1,943

Balance at 30 April 2019

972

3,030

140

8,696

(17)

284

3,981

17,086

 

 

 

 

 

 

 

 

 

Restatement for IFRS 16 ("Leases")

-

-

-

-

-

-

-

-

Balance at 01 May 2019

972

3,030

140

8,696

(17)

284

3,981

17,086

 

Notes to the interim financial statements

 

 

1. General information and basis of preparation

 

SDI Group plc (formerly known as Scientific Digital Imaging plc (the "Company")), a public limited company, is the Group's ultimate parent. It is registered in England and Wales. The consolidated interim financial statements of the Company for the period ended 31 October 2019 comprise the Company and its subsidiaries (together referred to as the "Group").

 

The unaudited consolidated interim financial statements are for the six months ended 31 October 2019. These interim financial statements have been prepared using the recognition and measurement principles of International Accounting Standards, International Financial Reporting Standards and Interpretations adopted for use in the European Union (collectively EU IFRS). The consolidated interim financial information has been prepared under the historical cost convention, as modified by the recognition of certain financial instruments at fair value. The consolidated interim financial statements are presented in British pounds (£), which is also the functional currency of the ultimate parent company.

 

The consolidated interim financial information was approved by the Board of Directors on 16 December 2019.

 

The financial information set out in this interim report does not constitute statutory accounts as defined in section 435 of the Companies Act 2006. The figures for the year ended 30 April 2019 have been extracted from the statutory financial statements of Scientific Digital Imaging plc which have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under section 498(2) or 498(3) of the Companies Act 2006. The financial information for the six months ended 31 October 2019 and for the six months ended 31 October 2018 has not been audited.

 

 

 

2. Principal accounting policies

The principal accounting policies adopted in the preparation of the condensed consolidated interim information are consistent with those followed in the preparation of the Group's financial statements for the year ended 30 April 2019, except that the Group has implemented IFRS 16 ("Leases") with effect from 1 May 2019.

The accounting policies have been applied consistently throughout the Group for the purposes of preparation of these interim financial statements.

 

IFRS 16 'Leases'

The Group has adopted IFRS 16 from 1 May 2019 and applied the modified retrospective approach. IFRS 16 provides a single on-balance sheet accounting model for lessees which recognises a right-of-use asset, representing its right to use the underlying asset, and lease liability, representing its obligations to make payment in respect of the use of the underlying asset. The accounting distinction between finance and operating leases for lessees is removed. Comparatives for the prior period have not been restated and the adjustments arising from the new leasing standard are therefore recognised in the opening balance sheet on 1 May 2019 as follows:

 

 

 

 

1 May 2019

Unaudited

£'000

Non-current assets

 

Property, plant and equipment (right of use assets)

2,477

Current assets

 

Trade and other receivables

(22)

Total assets

2,455

Non-current liabilities

 

Lease liabilities

1,999

Current liabilities

 

Lease liabilities

456

Total liabilities

2,455

Total movement in retained earnings as at 1 May 2019

-

 

On adoption of IFRS 16, the Group recognised liabilities for leases which had been classified as operating leases under previous accounting standards. The lease liability has been measured at the present value of the remaining lease payments, discounted using the incremental borrowing rate as at 1 May 2019. The weighted average lessee's incremental borrowing rate applied to the lease liabilities on 1 May 2019 was 3.1%.

 

 

 

 

1 May 2019

Unaudited

£'000

Operating lease commitments as disclosed at 30 April 2019

2,706

Adjustment to commitment disclosures

282

 

2,988

Effect of discounting (at incremental borrowing rate as at 1 May 2019)

(533)

Lease liability recognised as at 1 May 2019

2,455

 

The adjustment to commitment disclosures consists of recognition differences on new leases, different assumptions on break clauses and rent reviews, and short term and low value leases.

 

2. Principal accounting policies (continued)

 

Practical expedients applied

In applying IFRS 16 for the first time, the Group has used the following practical expedients permitted by the standard:

- Excluded initial direct costs for the measurement of right-of-use assets at the date of the initial application

- Used hindsight in determining the lease term where the contract contains options to extend or terminate the lease

 

Impact on the income statement

The impact on the income statement for the six months ended 31 October 2019 is to increase operating profit by approximately £10,000 and increase finance costs by £38,000 resulting in a decrease in profit before tax of £28,000. The impact on the income statement for the year ended 30 April 2020 is expected to increase operating profit by approximately £24,000 and increase finance costs by £81,000 resulting in a decrease in profit before tax of £57,000.

 

Impact on the cash flow statement

There has been a change to the classification of cash flows in the cash flow statement with operating lease payments previously categorised as operating cash flow now being split between the principal element, included as payments of lease liabilities within financing activities and the interest element, included as interest paid within cash generated from operating activities. In the six months to 31 October 2019 there were £228,000 of operating lease payments comprising £192,000 of payment of lease liabilities and £36,000 of interest paid.

 

Accounting policy

The Group recognises a right-of-use asset and a lease liability at the lease commencement date.

The right-of-use asset is initially measured at cost, comprising the initial amount of the lease liability plus any initial direct costs incurred and an estimate of costs to restore the underlying asset, less any lease incentives received. The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the asset or the end of the lease term. The right-of-use asset is included within property, plant & equipment in the balance sheet.

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the incremental borrowing rate. The lease liability is measured at amortised cost using the effective interest method. It is re-measured when there is a change in future lease payments arising from a change in an index or a rate or a change in the Group's assessment of whether it will exercise an extension or termination option. When the lease liability is re-measured, a corresponding adjustment is made to the right-of-use asset. The lease liability is included within borrowings in the balance sheet.

Payments associated with short-term leases or low-value assets are recognised on a straight-line basis as an expense in the income statement. Short-term leases are leases with a lease term of 12 months or less. Low-value assets mostly comprise of IT and office equipment.

 

 

3. Alternative Performance Measures

The Group uses Adjusted Operating Profit, Adjusted Profit Before Tax, Adjusted EPS and Net Operating Assets as supplemental measures of the Group's profitability and investment in business-related assets, in addition to measures defined under IFRS. The Group considers these useful due to the exclusion of specific items that are considered to hinder comparison of underlying profitability and investments of the Group's segments and businesses.

 

The following table is included to define the term Adjusted Operating Profit:

 

 

 

 

6 months to

31 October

2019

Unaudited

£'000

6 months to

31 October

2018

Unaudited

£'000

12 months to

30 April

2018

Audited

£'000

 

 

 

 

Operating Profit (as reported)

1,621

1,229

2,198

 

 

 

 

Adjusting items (all costs):

 

 

 

Reorganisation costs

59

4

124

Share based payments

140

48

136

Acquisition and fundraising costs

-

60

288

Amortisation of acquired intangible assets

282

153

356

Total adjusting items within Operating Profit

481

265

904

 

 

 

 

Adjusted Operating Profit

2,102

1,494

3,102

 

 

Adjusted Profit Before Tax is defined as follows:

 

 

 

6 months to

31 October

2019

Unaudited

£'000

6 months to

31 October

2018

Unaudited

£'000

12 months to

30 April

2018

Audited

£'000

 

 

 

 

Profit before tax (as reported)

1,517

1,199

2,121

 

 

 

 

Adjusting items (as above)

481

265

904

 

 

 

 

Adjusted Profit Before Tax

1,998

1,464

3,025

 

 

3. Alternative Performance Measures (continued)

 

Adjusted EPS is defined as follows:

 

 

 

6 months to

31 October

2019

Unaudited

£'000

6 months to

31 October

2018

Unaudited

£'000

12 months to

30 April

2018

Audited

£'000

 

 

 

 

Profit for the period (as reported)

1,328

996

1,912

 

 

 

 

Adjusting items (as above)

481

265

904

Less taxation on adjusting items calculated at the UK statutory rate

 

(91)

 

(50)

 

(172)

Adjusted net profit

1,718

1,211

2,644

 

 

 

 

Divided by diluted weighted average number of shares in issue (Note 5)

100,846,707

91,202,266

93,330,500

 

 

 

 

 

 

 

 

Adjusted diluted EPS

1.70p

1.33p

2.83p

 

 

Net Operating Assets is defined as follows:

 

 

 

 

31 October

2019

Unaudited

£'000

31 October

2018

Unaudited

£'000

30 April

2018

Audited

£'000

 

 

 

 

Net assets

18,597

13,719

17,086

 

 

 

 

Deferred tax asset

182

27

180

Cash and cash equivalents

2,727

2,307

2,494

Borrowings (current and non-current)

(5,807)

(1,412)

(4,100)

Deferred tax liability

(1,356)

(1,033)

(1,449)

Current tax payable

(597)

(494)

(626)

Total adjusting items within Net assets

(4,851)

(605)

(3,501)

 

 

 

 

Net Operating Assets

23,448

14,324

20,586

 

 

4. Segmental analysis

 

 

 

6 months to

31 October

2019

Unaudited

 

£'000

6 months to

31 October

2018

Unaudited

Restated

£'000

12 months to

30 April

2019

Audited

 

£'000

Revenues

 

 

 

Digital Imaging

5,639

4,305

9,434

Sensors & Control

5,806

3,672

7,993

Other

-

70

-

Group

11,445

8,047

17,427

 

 

 

 

Adjusted Operating Profit

 

 

 

Digital Imaging

1,210

1,023

1,954

Sensors & Control

1,361

915

2,165

Other

(469)

(444)

(1,017)

Group

2,102

1,494

3,102

 

 

 

 

Amortisation of acquired intangible assets

 

 

 

Digital Imaging

90

7

50

Sensors & Control

192

146

306

Other

-

-

-

Group

282

153

356

 

A reconciliation of Adjusted Operating Profit to Operating Profit for the Group is provided in Note 3.

Analysis of amortisation of acquired intangible assets has been included separately as the Group considers it to be an important component of profit which is directly attributable to the reported segments.

The Other category includes costs which cannot be allocated to the other segments, and consists principally of Group HQ costs.

The analysis for the 6 months to October 2018 has been restated to allocate Fistreem revenues and costs to the Digital Imaging segment. In the Interim Report for the 6 months to October 2018, these had been shown in the Other segment, pending a decision on the appropriate reporting segment for Fistreem activities.

 

4. Segmental analysis (continued)

 

 

 

 

31 October

2019

Unaudited

 

£'000

31 October

2018

Unaudited

Restated

£'000

30 April

2019

Audited

 

£'000

Operating assets excluding acquired intangible assets

 

 

 

Digital Imaging

6,508

4,512

4,828

Sensors & Control

4,110

2,036

3,020

Other

53

2

27

Group

10,671

6,549

7,875

 

 

 

 

Acquired intangible assets

 

 

 

Digital Imaging

5,461

2,176

5,552

Sensors & Control

10,260

8,003

10,451

Other

-

-

-

Group

15,721

10,179

16,003

 

 

 

 

Liabilities

 

 

 

Digital Imaging

(1,185)

(1,140)

(1,281)

Sensors & Control

(1,514)

(1,083)

(1,361)

Other

(245)

(181)

(649)

Group

(2,944)

(2,404)

(3,291)

 

 

 

 

Net Operating Assets

 

 

 

Digital Imaging

10,784

5,548

9,099

Sensors & Control

12,856

8,956

12,110

Other

(192)

(180)

(623)

Group

23,448

14,324

20,586

 

A reconciliation of Net Operating Assets to net assets for the Group is provided in Note 3.

The Other category includes assets and liabilities which cannot be allocated to the other segments.

The analysis for 31 October 2018 has been restated to allocate Fistreem operating assets and liabilities to the Digital Imaging segment. In the Interim Report for the 6 months to October 2018, these had been shown in the Other segment, pending a decision on the appropriate reporting segment for Fistreem activities.

 

 

5. Earnings per share

The calculation of the basic earnings per share is based on the profits attributable to the shareholders of SDI Group plc divided by the weighted average number of shares in issue during the period. All profit per share calculations relate to continuing operations of the Group.

 

 

 

Profit

 attributable to

shareholders

£'000

Weighted

average

number of

shares

Earnings

per share

amount in

pence

Basic earnings per share:

 

 

 

Period ended 31 October 2019

1,328

97,203,951

1.37

Period ended 31 October 2018

996

89,115,396

1.12

Year ended 30 April 2019

1,912

91,209,753

2.10

 

 

 

 

Dilutive effect of share options:

 

 

 

Period ended 31 October 2019

 

3,642,756

 

Period ended 31 October 2018

 

1,568,842

 

Year ended 30 April 2019

 

2,120,747

 

 

 

 

 

Diluted earnings per share:

 

 

 

Period ended 31 October 2019

1,328

100,846,707

1.32

Period ended 31 October 2018

996

91,202,266

1.10

Year ended 30 April 2019

1,912

93,330,500

2.05

 

 

 

6. Borrowings

 

31 October

2019

£'000

31 October

2018

£'000

30 April

2019

£'000

Within one year:

 

 

 

Bank finance

-

-

-

Lease liabilities (formerly only finance leases)

449

34

84

 

449

34

84

After one year and within five years:

 

 

 

Bank finance

3,300

1,370

4,000

Lease liabilities (formerly only finance leases)

1,103

8

16

 

4,403

1,378

4,016

After more than five years:

 

 

 

Lease liabilities (formerly only finance leases)

955

-

-

 

 

 

 

Total borrowings

5,807

1,412

4,100

 

Bank finance for 31 October 2019 relates to amounts drawn down under the Group's £5,000,000 revolving bank facility with HSBC UK Bank plc. The termination date of the facility is 3 April 2023.

Subsequent to the end of the period, the Group has agreed an additional £4,800,000 amortising facility with HSBC UK Bank plc which has the same termination date of 3 April 2023.

Leases at 31 October 2018 and 30 April 2019 include only finance leases. Following adoption of IFRS 16 from 1 May 2019, there is no longer an accounting distinction between finance and operating leases (see Note 2). On 1 May 2019, £2,455,000 of liabilities from leases formerly classified as operating leases were recognised, of which £456,000 were due within one year.

 

 

 

7. Post Balance Sheet Event

On 29 November 2019 the Group completed the acquisition of Chell Instruments Limited ("Chell") for an initial consideration of £4.3m plus an additional cash payment, still to be determined, for net assets at completion. Chell specialises in the design, manufacture and calibration of pressure, vacuum and gas flow measurement instruments for a variety of sectors including aerospace, vehicle aerodynamics, gas and steam turbine testing and power generation industries. For the year ended 31 December 2018, Chell achieved revenue of £4.7m, gross profit of £2.5m and profit before tax of £0.78m. The Board has identified areas within Chell that have the potential for growth using the strong management team the company has recruited over the years. The Acquisition is expected to be earnings enhancing in its first full year of ownership.

 

Associated with the acquisition, the Group agreed and drew down an additional £4.8m borrowing facility with its bank HSBC UK Bank plc.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR EANAKFEANFFF
Date   Source Headline
3rd Apr 20242:15 pmRNSExercise of Share Options and Total Voting Rights
18th Mar 202412:49 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20243:15 pmRNSHolding(s) in Company
26th Feb 20247:00 amRNSLong Term Incentive Plan Awards
23rd Feb 202411:00 amRNSHolding(s) in Company
21st Feb 20246:00 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSHolding(s) in Company
13th Feb 202411:14 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSDirectorate Change – Appointment of New CEO
8th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 20232:30 pmRNSHolding(s) in Company
7th Dec 20231:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSInterim Results
4th Dec 20237:00 amRNSNotice of Results and Investor Presentation
7th Nov 20234:10 pmRNSDirector/PDMR Shareholding
7th Nov 20233:50 pmRNSDirector/PDMR Shareholding and TVR - Replacement
7th Nov 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
6th Nov 20237:00 amRNSAcquisition of Peak Sensors
31st Oct 20234:20 pmRNSHolding(s) in Company
26th Oct 20235:45 pmRNSHolding(s) in Company
29th Sep 202311:30 amRNSResult of AGM
29th Sep 20237:00 amRNSAGM Trading Update
24th Aug 20237:00 amRNSBoard Appointment
8th Aug 20237:00 amRNSFinal Results
2nd Aug 20237:00 amRNSNotice of Results and Investor Presentation
26th May 20231:40 pmRNSHolding(s) in Company
16th May 20232:55 pmRNSHolding(s) in Company
11th May 202311:50 amRNSDirector Dealing
11th May 20237:00 amRNSTrading Update
19th Apr 20231:00 pmRNSDirector/PDMR Shareholding and TVR
12th Apr 20235:15 pmRNSDirector/PDMR Shareholding
31st Mar 20233:45 pmRNSDirector Dealing
15th Mar 202312:00 pmRNSHolding(s) in Company
15th Feb 20235:30 pmRNSHolding(s) in Company
13th Feb 20233:55 pmRNSHolding(s) in Company
3rd Feb 20232:00 pmRNSExercise of Options and Total Voting Rights
1st Feb 202310:15 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBoard Appointment
5th Jan 202310:00 amRNSExercise of Options and Total Voting Rights
14th Dec 20224:00 pmRNSExercise of Options and Total Voting Rights
7th Dec 20227:00 amRNSInterim Results
7th Nov 20227:00 amRNSInvestor Presentation
3rd Nov 20227:00 amRNSNotice of Results
27th Oct 20223:55 pmRNSDirector Dealings, Exercise of Options and TVR
26th Oct 20227:00 amRNSLong Term Incentive Plan Awards
24th Oct 20227:00 amRNSAcquisition of Fraser Anti-Static Techniques Ltd
21st Sep 20224:15 pmRNSResult of AGM and Board Appointment
21st Sep 20227:00 amRNSAGM Trading Update
24th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.